Lymphoproliferative Disorders  >>  Genasense (oblimersen)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Genasense (oblimersen) / Genta
NCT00024440: Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Completed
3
US
filgrastim, oblimersen sodium, cyclophosphamide, fludarabine phosphate
Genta Incorporated
Leukemia
 
02/07
NCT00017602: Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma

Completed
3
US
oblimersen sodium, dexamethasone
Genta Incorporated
Multiple Myeloma and Plasma Cell Neoplasm
 
04/09

Download Options